The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124717833 12471783 3 F 2016 20160629 20160616 20160711 EXP CA-ALEXION PHARMACEUTICALS INC-A201604340 ALEXION 60.57 YR F Y 77.98000 KG 20160711 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124717833 12471783 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, QW 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
124717833 12471783 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W AE1229B05 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
124717833 12471783 3 C NOVO-CLONIDINE 2 Oral 1.25 MG, QD 0 1.25 MG QD
124717833 12471783 4 C NOVO-CLONIDINE 2 Oral 0.625 MG, QD 0 .625 MG QD
124717833 12471783 5 C EURO FOLIC 2 Oral 5 MG, QW 0 5 MG /wk
124717833 12471783 6 C EURO FOLIC 2 0
124717833 12471783 7 C PROTYLOL 2 Oral 20 MG, Q6H AS NEEDED 0 20 MG Q6H
124717833 12471783 8 C CALCIUM CALCIUM 1 Oral 300 MG, TID 0 300 MG TID
124717833 12471783 9 C VITAMIN D /00107901/ ERGOCALCIFEROL 1 Oral 1000 IU, QD 0 1000 IU QD
124717833 12471783 10 C CENTRUM FOR WOMEN VITAMINS 1 Oral UNK, QD 0 QD
124717833 12471783 11 C TYLENOL ACETAMINOPHEN 1 Oral 500 MG, PRN 0 500 MG /yr
124717833 12471783 12 C TYLENOL ACETAMINOPHEN 1 0
124717833 12471783 13 C TYLENOL ACETAMINOPHEN 1 0
124717833 12471783 14 C RHINARIS /00678601/ 2 Topical UNK UNK, BID 0 BID
124717833 12471783 15 C GENACOL /00724201/ 2 Oral UNK, QD 0 TABLET QD
124717833 12471783 16 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Oral 1-2 TABS, QHS 0 TABLET QD
124717833 12471783 17 C SALINEX /00075401/ 2 Nasal UNK, PRN 0 /yr
124717833 12471783 18 C ROBITUSSIN (GUAIFENESIN) GUAIFENESIN 1 Oral 1 TABLESPOON, AT NIGHT 0 SYRUP
124717833 12471783 19 C NASONEX MOMETASONE FUROATE 1 Nasal UNK, QD (2 SPRAY IN EACH NOSTRILS) 0 QD
124717833 12471783 20 C ARTECHOL 2 Oral UNK, PRN 0 CAPSULE /yr
124717833 12471783 21 C SULFAPRIM 2 Oral 800 MG-160 MG, QD (1 CO) 0 QD
124717833 12471783 22 C COLLAGEN COLLAGEN 1 Unknown UNK, PRN (1/2 TABLE SPOON) 0 /yr
124717833 12471783 23 C CHLOROPHYLL 2 Unknown UNK 0
124717833 12471783 24 C GLUCOSAMINE CHONDROITIN + MSM CHONDROITIN SULFATE (BOVINE)DIMETHYL SULFONEGLUCOSAMINE SULFATE 1 Unknown UNK 0
124717833 12471783 25 C CELEBREX CELECOXIB 1 Unknown UNK 0
124717833 12471783 26 C COLACE DOCUSATE SODIUM 1 Oral 200 MG, BID 0 200 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124717833 12471783 1 Paroxysmal nocturnal haemoglobinuria
124717833 12471783 3 Hypertension
124717833 12471783 5 Supplementation therapy
124717833 12471783 6 Paroxysmal nocturnal haemoglobinuria
124717833 12471783 7 Product used for unknown indication
124717833 12471783 8 Product used for unknown indication
124717833 12471783 9 Supplementation therapy
124717833 12471783 10 Supplementation therapy
124717833 12471783 11 Pyrexia
124717833 12471783 12 Pain
124717833 12471783 13 Headache
124717833 12471783 14 Product used for unknown indication
124717833 12471783 15 Supplementation therapy
124717833 12471783 16 Pain
124717833 12471783 17 Nasal discharge discolouration
124717833 12471783 18 Product used for unknown indication
124717833 12471783 19 Sinusitis
124717833 12471783 20 Product used for unknown indication
124717833 12471783 21 Prophylaxis
124717833 12471783 22 Myalgia
124717833 12471783 23 Product used for unknown indication
124717833 12471783 24 Vitamin supplementation
124717833 12471783 25 Pain
124717833 12471783 26 Constipation

Outcome of event

Event ID CASEID OUTC COD
124717833 12471783 HO
124717833 12471783 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124717833 12471783 Asthenia
124717833 12471783 Chest pain
124717833 12471783 Cough
124717833 12471783 Diarrhoea
124717833 12471783 Dysphonia
124717833 12471783 Fatigue
124717833 12471783 Haemoglobin decreased
124717833 12471783 Insomnia
124717833 12471783 Neck pain
124717833 12471783 Neutropenia
124717833 12471783 Oropharyngeal pain
124717833 12471783 Pancytopenia
124717833 12471783 Pyrexia
124717833 12471783 Sinus pain
124717833 12471783 Sinusitis
124717833 12471783 Sputum discoloured

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124717833 12471783 1 20101201 20101222 0
124717833 12471783 2 20101228 0
124717833 12471783 3 20131031 201401 0
124717833 12471783 4 201401 0
124717833 12471783 5 20110608 0
124717833 12471783 10 20100101 0
124717833 12471783 14 20120320 0
124717833 12471783 15 20120410 0
124717833 12471783 17 20121203 0
124717833 12471783 18 20130104 0
124717833 12471783 19 20130314 0
124717833 12471783 21 20141004 0
124717833 12471783 22 201501 0
124717833 12471783 23 201502 0
124717833 12471783 24 201503 0
124717833 12471783 25 20150413 0